American College of Lifestyle Medicine publishes official position on lifestyle medicine as a framework for delivery of high-value, whole-person care
Peer-Reviewed Publication
Updates every hour. Last Updated: 27-Dec-2025 10:11 ET (27-Dec-2025 15:11 GMT/UTC)
The drug, ziftomenib. will benefit patients with recurring or treatment-resistant acute myeloid leukemia who have no other options.
A European consortium of researchers has developed a new decision making framework for health professionals which they hope will transform the care of patients with chronic obstructive pulmonary disease (COPD).A European consortium of researchers has developed a new decision making framework for health professionals which they hope will transform the care of patients with chronic obstructive pulmonary disease (COPD).